Why the CSL share price just raced to an all-time high

The CSL Limited (ASX:CSL) share price just hit an all-time high. Here's why its shares have been on form recently…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price continued its strong run on Thursday and charged higher again.

The biotherapeutics company's latest gain means its shares have just hit an all-time high of $291.46.

Why did the CSL share price hit an all-time high?

The catalyst for yesterday's solid gain was the de-escalation of US-Iran tensions and the release of a positive broker note out of Credit Suisse.

In respect to the latter, the broker retained its outperform rating and $305.00 price target on the company's shares.

According to the note, the broker's data shows that immunoglobulins demand remains strong and it feels CSL is well-positioned to benefit greatly from the high prices and tight market.

What else is driving its share price higher?

Investors have been fighting to buy CSL's shares following a very strong performance in FY 2019.

During the 12 months CSL grew its revenue by 11% to US$8,539 million and net profit after tax at a quicker rate of 17% to US$1,919 million. Key drivers of this were strong demand for its immunoglobulins and albumin products.

Sales of immunoglobulins grew at an above-market rate of 16% to US$3,543 million in FY 2019. This was thanks to a range of factors including increased usage for chronic therapies, growing awareness and diagnosis, and the expanding usage for secondary immunodeficiency.

This ultimately led to the core CSL Behring business delivering an 11% increase in total revenue to US$7,343 million.

Supporting its growth was the Seqirus influenza vaccine business. Thanks to strong demand for its seasonal influenza vaccines, it posted a 12% increase in total revenue to US$1,196 million.

What about the future?

The good news is that brokers like Credit Suisse appear confident that there will be more of the same in FY 2020 thanks to favourable market conditions.

And with its R&D pipeline filled with promising products, the future looks bright for this biotherapeutics giant.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
52-Week Highs

13 ASX 200 shares at 52-week highs

These shares are making their shareholders smile on Thursday.

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
52-Week Highs

These 5 ASX 200 shares just hit new 52-week highs

Do you own any of these five lucky stocks?

Read more »

ETF on white blocks with a rising arrow on top of coin piles.
52-Week Highs

12 ASX ETFs breaking the mould to hit 52-week highs today

What a day for ASX ETF investors!

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
52-Week Highs

Why is the A2 Milk share price up 46% year to date and at a 52-week high?

This infant formula company's shares have delivered the goods this year.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Travel Shares

Why is the Webjet share price racing to a 52-week high today?

Webjet has been busy talking up its WebBeds business this morning.

Read more »

Man pointing at a blue rising share price graph.
Financial Shares

Big ASX news: Macquarie share price hits new 52-week high

It's been a great day to own Macquarie shares...

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
52-Week Highs

Metcash share price hits 52-week high on broker upgrade: Time to buy?

Brokers have responded positively to its trading update.

Read more »

a woman sits amid a stylish home setting on a sofa with plush cushions with a coffee table and plant in the foreground while she peruses a tablet device.
52-Week Highs

52-week high! ASX All Ords stock surges 5% as chair steps down

Investors are shopping for Adairs shares after an announced leadership change.

Read more »